TURKEL CATHERINE C. 4
4 · Novus Therapeutics, Inc. · Filed Sep 30, 2019
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-09-26+75,000→ 75,000 totalExercise: $0.67Exp: 2029-09-26→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 75,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.